Amway (Malaysia) Holdings Berhad Q2 2025 Latest Quarterly Report Analysis

“`html Amway Malaysia’s Q2 2025 Results: Navigating a Tough Market Amway (Malaysia) Holdings Berhad has just released its financial results for the second quarter ending June 30, 2025, painting a picture of a company navigating significant economic headwinds. The latest report reveals a sharp decline in both revenue and profitability, reflecting the challenging consumer landscape….

SHANGRI-LA HOTELS (MALAYSIA) BERHAD Q2 2025 Latest Quarterly Report Analysis

Shangri-La Malaysia Q2 2025 Earnings Review Shangri-La Malaysia Q2 2025: Profit Soars Over 120% Despite Revenue Dip, Interim Dividend Declared! Shangri-La Hotels (Malaysia) Berhad, a cornerstone of Malaysia’s luxury hospitality industry, has just released its financial results for the second quarter ended June 30, 2025. The report reveals a fascinating story of operational excellence and…

TSH Resources Berhad

TSH Resources Berhad 2QFY25 Results Review: Momentum Carries Through MBSB RESEARCH Corporate Update Thursday 21st. August 2025 TSH Resources Berhad (9059 | TSH MK) Main | Plantation ESG 4 Stars SHARIAH Compliant 2QFY25 Results Review: Momentum Carries Through Maintain NEUTRAL Revised Target Price RM1.23 (from RM1.16) RETURN STATISTICS Price @ 20 Aug 2025 (RM) 1.16…

TSH Resources Berhad: Still Providing Upside Potential

TSH Resources Berhad: Still Providing Upside Potential ► TA SECURITIES A MEMBER OF THE TA GROUP RESULTS UPDATE Thursday, August 21, 2025 FBMKLCI: 1,588.21 Sector: Plantation THIS REPORT IS STRICTLY FOR INTERNAL CIRCULATION ONLY* TSH Resources Berhad: Still Providing Upside Potential Angeline Chin Tel: +603-2167 9611 angelinechin@ta.com.my TP: RM1.30 (+11.9%) Last Traded: RM1.16 Rating: BUY…

APEX HEALTHCARE BERHADDragged By Weaker Associate Contribution

APEX HEALTHCARE BERHAD Dragged By Weaker Associate Contribution PUBLIC INVESTMENT BANK Thursday, August 21, 2025 PublicInvest Research Results Review KDN PP17686/03/2013(032117) APEX HEALTHCARE BERHADDragged By Weaker Associate Contribution Rating Neutral DESCRIPTION An investment holding company involved in the development, manufacturing, marketing and distribution of pharmaceuticals, diagnostics, consumer healthcare products and orthopaedic devices. 12-Month Target PriceRM2.28…